Health news round-up: relabelling prostate cancer, zoonotic diseases and e-cigarette chemicals The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Everything you need to know about GLP-1s for weight loss From semaglutide to tirzepatide, this article collates the latest information on pharmacological weight-loss treatments, including evidence and best practice for their use.…
Hospitals owe wholesalers £43m in unpaid medicines bills Exclusive: The Healthcare Distribution Association told The Pharmaceutical Journal that it has written to NHS England and emphasised that the overdue debt is an “issue both in primary care and in secondary care”.…
Call to reclassify morning-after pill as general sales list item The College of Sexual and Reproductive Healthcare has called for emergency hormonal contraception to be sold in shops alongside condoms and pregnancy tests to increase women's autonomy over their reproductive health.…
NICE issues first UK guidance for PMOS treatment The National Institute for Health and Care Excellence guidance offers advice on the management of polyendocrine metabolic ovarian syndrome and its associated symptoms.…
Call for government support as record price concessions hit 250 mark Community Pharmacy England has announced that 254 price concessions were granted by the government in England in June 2026, which is more than double the amount of concessions this time last year.…
National formulary will make shortages worse, suggests NPA chair Olivier Picard told delegates at the Community Pharmacy and General Practice Conference that a single national formulary could “restrict“ the entry of medicines into the country's market.…
Health news round-up: contraception, obesity inequalities and eating disorders on GLP-1s The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
NHS implementation of NICE recommendations ‘not joined up enough’, says chief executive Speaking at a House of Lords Science Technology Committee session, Jonathan Benger said that newly approved medicines are not returning on investment in the way that companies have hoped for.…
Patients at risk of harm over lack of shared access to NHS records An investigation has found that clinicians may be missing "vital" patient information, owing to limited access to NHS records.…
